Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03594578 · ClinicalTrials.gov registry record · NA
Prospective Thinking in Hormone-Responsive Breast Cancer
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT03594578 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 89 participants.
The verdict
NCT03594578, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
One factor that limits the effectiveness of adjuvant hormone therapy for breast cancer is medication nonadherence. Adherence to long-term medication regimens requires valuation of temporally distant outcomes. Thus, interventions that improve valuation of the future, a phenomenon known as delay discounting, may improve medication adherence in breast cancer treatment and improve survival. This study will investigate the acute efficacy of a prospective thinking intervention (episodic future thinking) for reducing delay discounting and improving valuation of future health in breast cancer patients. Patients will engage in either episodic future thinking or a control condition during completion of delay discounting tasks in which they choose between immediate and delayed outcomes.
Interventions
- BEHAVIORAL Episodic future thinking
- BEHAVIORAL Episodic recent thinking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2019-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03594578
The ClinicalTrials.gov registry entry for NCT03594578 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Episodic future thinking is the first listed.
NCT03594578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03594578 about?
NCT03594578 is a clinical study titled "Prospective Thinking in Hormone-Responsive Breast Cancer". One factor that limits the effectiveness of adjuvant hormone therapy for breast cancer is medication nonadherence. Adherence to long-term medication regimens requires valuation of temporally distant outcomes. Thus, interventions that improve valuation of the future, a phenomenon known as delay disco...
What is the current status of trial NCT03594578?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2018-08-01. Estimated completion is 2019-09-20.
What interventions are being tested in trial NCT03594578?
The interventions under investigation include: Episodic future thinking (BEHAVIORAL), Episodic recent thinking (BEHAVIORAL).
Who is sponsoring clinical trial NCT03594578?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.